Calamos Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.1M Buy
48,868
+495
+1% +$249K 0.08% 252
2025
Q4
$22.6M Sell
48,373
-1,964
-4% -$912K 0.08% 242
2025
Q3
$21.5M Hold
50,337
0.08% 267
2025
Q2
$19.3M Hold
50,337
0.08% 276
2025
Q1
$17.4M Buy
50,337
+561
+1% +$180K 0.08% 281
2024
Q4
$14.9M Sell
49,776
-85
-0.2% -$29.7K 0.06% 318
2024
Q3
$20.3M Sell
49,861
-1,136
-2% -$416K 0.09% 269
2024
Q2
$16.4M Sell
50,997
-1,861
-4% -$605K 0.07% 287
2024
Q1
$17.6M Sell
52,858
-1,329
-2% -$406K 0.08% 274
2023
Q4
$14.7M Sell
54,187
-708
-1% -$175K 0.07% 310
2023
Q3
$13.5M Hold
54,895
0.07% 323
2023
Q2
$16.7M Hold
54,895
0.08% 299
2023
Q1
$14.5M Sell
54,895
-6,863
-11% -$1.74M 0.07% 336
2022
Q4
$14.8M Sell
61,758
-10,920
-15% -$2.45M 0.07% 337
2022
Q3
$13.4M Hold
72,678
0.06% 371
2022
Q2
$12.2M Buy
72,678
+1,914
+3% +$411K 0.05% 430
2022
Q1
$17.7M Buy
70,764
+9,469
+15% +$2.38M 0.07% 326
2021
Q4
$15.7M Buy
61,295
+2,373
+4% +$581K 0.06% 341
2021
Q3
$14.3M Buy
58,922
+5,200
+10% +$1.27M 0.06% 325
2021
Q2
$11.1M Buy
53,722
+12,219
+29% +$2.49M 0.05% 373
2021
Q1
$7.82M Buy
41,503
+1,283
+3% +$226K 0.04% 395
2020
Q4
$6.62M Sell
40,220
-1,742
-4% -$255K 0.04% 427
2020
Q3
$5.23M Sell
41,962
-53,683
-56% -$6.64M 0.03% 452
2020
Q2
$9.28M Buy
95,645
+47,080
+97% +$4.89M 0.07% 312
2020
Q1
$4.36M Sell
48,565
-4,070
-8% -$527K 0.03% 423
2019
Q4
$7.78M Sell
52,635
-867
-2% -$116K 0.04% 414
2019
Q3
$6.44M Sell
53,502
-2,287
-4% -$296K 0.04% 453
2019
Q2
$7.54M Buy
55,789
+7,832
+16% +$990K 0.04% 412
2019
Q1
$6.25M Buy
47,957
+466
+1% +$62.6K 0.04% 414
2018
Q4
$5.91M Buy
47,491
+8,312
+21% +$1.12M 0.04% 405
2018
Q3
$5.45M Buy
+39,179
New +$4.88M 0.03% 445
2017
Q3
Sell
-146,641
Closed -$12.8M 633
2017
Q2
$12.8M Sell
146,641
-4,511
-3% -$382K 0.09% 252
2017
Q1
$13.5M Sell
151,152
-8,387
-5% -$699K 0.11% 249
2016
Q4
$11.8M Buy
+159,539
New +$11.9M 0.09% 241
2016
Q2
Sell
-842,731
Closed -$65.8M 626
2016
Q1
$65.8M Buy
842,731
+10,661
+1% +$744K 0.44% 61
2015
Q4
$56.3M Buy
832,070
+85,772
+11% +$5.98M 0.36% 81
2015
Q3
$57.7M Buy
+746,298
New +$66.1M 0.4% 74

Other funds holding HCA

Calamos Advisors's HCA Position: Q1 2026 in Review

Calamos Advisors increased its HCA Healthcare (HCA) stake by 1% in Q1 2026, buying an estimated $249K and bringing the position to 48,868 shares worth $23.1M. The position accounts for 0.08% of the portfolio, ranked #252.

Calamos Advisors first reported a position in HCA in Q3 2015 and has held it in 37 quarters since. The position peaked at $65.8M in Q1 2016. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Calamos Advisors held 48,868 shares of HCA Healthcare worth $23.1M as of Q1 2026.
  • Calamos Advisors bought 495 HCA Healthcare shares in Q1 2026, an estimated $249K.
  • HCA Healthcare made up 0.08% of Calamos Advisors's portfolio in Q1 2026, its #252 holding.
  • Calamos Advisors first reported a position in HCA Healthcare in Q3 2015 and has held it in 37 quarters since.
  • Calamos Advisors's HCA Healthcare position peaked at $65.8M in Q1 2016.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.